Antiangiogenic therapy of established tumors in human skin/SCID mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide
収録刊行物
-
- Cancer Res
-
Cancer Res 2000